Palliative Care Pearls: What Works, What Doesnt I have no financial - - PDF document

palliative care pearls what works what doesn t
SMART_READER_LITE
LIVE PREVIEW

Palliative Care Pearls: What Works, What Doesnt I have no financial - - PDF document

3/22/2017 Disclosures Palliative Care Pearls: What Works, What Doesnt I have no financial disclosures to report. B R O O K CA L TO N , M D , M H S A S S I S TA N T P R O F E S S O R O F CL I N I CA L M E D I CI N E D I V I S I O N O


slide-1
SLIDE 1

3/22/2017 1

B R O O K CA L TO N , M D , M H S A S S I S TA N T P R O F E S S O R O F CL I N I CA L M E D I CI N E D I V I S I O N O F G E R I A TR I CS U N I V E R S I TY O F CA LI F O R N I A , S A N F R A N CI S CO

Palliative Care Pearls: What Works, What Doesn’t

Disclosures

I have no financial disclosures to report.

First, the bad news--- What Doesn’t Work…

1.

Docusate

  • 2. Chemotherapy Near End of Life
  • 3. IV Hydration Near End of Life
  • 4. Oxygen in Non-Hypoxic Patients with Dyspnea

Docusate for Constipation

 Study: Double-blind

RCT

 74 patients, 3

inpatient Canadian hospices

 Randomized to 10

days of:

 Senna 1-3 tabs/ day

+ docusate 100 mg BID

 Senna 1-3 tabs/ day

+ placebo BID

Tarumi Y. J Pain Symptom Manage. 2013;45(1):2-13

slide-2
SLIDE 2

3/22/2017 2

Study Results

 Docusate group had marginally larger volume of

stool p=0.06; stool consistency was slightly different between groups

 No differences in:

 Average # of bowel movements/ day  Patients’ perceptions of the difficulty or completeness of

defecation

 Pain  Percent of patients requiring additional bowel intervention

(74% placebo; 69% docusate)]  Additional issues: tastes horrible, pill burden

Take-Homes

No appreciable benefit of adding Docusate to Senna in hospice patients

 What works for constipation:

 Always rx laxative with opioid  Start with senna, then add Miralax, Lactulose, etc  Suppository or enema (avoid Fleets) if > 3-4 days  Consider Methylnatrexone for opioid-induced

constipation if above not working

Chemotherapy near End of Life

 Goals of chemotherapy

for patients with metastatic cancer:

1.

Live longer

2.

Live better  Study: Association of

chemo in last 6 months

  • f life with caregiver-

reported quality of life in last week of life and survival

Prigerson HG. Jama Oncol 2015; 1(6):778-784

 ½ of patients were on chemo at enrollment  Median survival 4 months  Patients with good functional status were more likely

to receive chemo

 Results:

 No difference in survival  Chemo associated with worse QoL for patients with better

functional status at baseline

Prigerson HG et al. Jama Oncol 2015; doi:10.1001/jamaoncol.2015.2378

Study Results

Think twice about whether to support palliative chemotherapy for patients with metastatic cancer who are near the end of life.

slide-3
SLIDE 3

3/22/2017 3

IV Hydration Near End of Life

 Significant controversy  Stopping to eat and drink at end of life is

normal

 Associated with edema, effusions and ascites  Does not reduce thirst  Requires some sort of access/ line

IV Hydration Near End of Life

 RCT of 129 hospice patients with cancer and mild-

moderate dehydration

 Intervention:

 1L NS/ day over 4 hours x 4 days  100mL NS/ day over 4 hours x 4 days Bruera E. J Clin Oncol. 2013; 31, no. 1 111-118

Study Results

 No stat sig difference in:

 Survival (21 vs 15 d)  Symptoms (fatigue,

myoclonus, sedation, hallucinations)

 Quality of Life

 Both groups noted

subjective improvement in dehydration symptoms

Typically best to minimize IVF at end of life.

Supplemental Oxygen for Dyspnea In Non-Hypoxic Patients  Palliative oxygen therapy widely used for

dyspnea

 Potential benefits: placebo effect, family

feels like “doing something”

 Potential burdens: ties patient down, social

stigma, uncomfortable, nosebleeds, fire risk

slide-4
SLIDE 4

3/22/2017 4

Supplemental Oxygen Trial

 Study:

 Double-blind RCT  239 outpatients in US, Australia and UK with life-

limiting illness, refractory dyspnea, and PaO2>55m Hg

 Randomized to RA or O2 at 2 LPM x 7 days Instructed to use O2 at least 15 hours/ day

Abernathy A. Lancet 2010;376(9743):784-93

Study Results

 No difference between supp O2 vs RA by NC in:

Mean AM Breathlessness scores Mean PM Breathlessness scores Quality of Life

Compared with RA NC, oxygen by NC provides no benefit for dyspnea in patients who are not hypoxemic.

What Works for Dyspnea

 Treat the underlying cause

 Pleural effusion, PE, pna, ascites

 Opioids

 Low dose, Safe even in COPD

 Position  Breathing training  Fan and/ or fresh air  Cold cloth to face  Acupuncture in COPD

Ekstrom M. Ann Am Thoracic Soc 2015; 12(7):1079-92 Bausewein C. Cochrane Database Syst Rev. 2008(2):CD005623

And now, the good news--- (Other Things) That Work!

Palliative Care Skillful and Sensitive Communication Advance Care Planning

slide-5
SLIDE 5

3/22/2017 5

Palliative Care

 Specialized medical care for patients with serious

illness and their families

 Focuses on providing relief from the symptoms and

stress of a serious illness

 Team-based approach  No prognostic or treatment limitations  Hospice is a type of palliative care

 A Medicare Benefit (Part A)  For patients with prognosis less than six months who have

chosen to forgo life-prolonging interventions

 Can be offered at home, SNF, or other residential facility

Old Paradigms of Palliative Care Engagement

Current Paradigm of Palliative Care Engagement

Condition appropriate for palliative care may or may NOT progress to death

Palliative Care Benefits

Quality Im proves

 Reduction in symptom burden  Improved quality of life  Longer length of life  Increased family satisfaction  Better family bereavement outcomes  Care matched to patient centered goals

Costs Decrease

 Hospital costs decrease  Need for hospitalization/ ICU decreases

slide-6
SLIDE 6

3/22/2017 6

Early Palliative Care Intervention

 Study:

 Non-blinded, RCT (single

site)

 Ambulatory patients with

newly diagnosed metastatic NSCLC

 Immediate PC + onc vs onc  Primary outcome: change in

QOL at 12 weeks

Temel J. N Engl J Med 2010;363:733-42

Study Results

 Baseline characteristics did

not differ between groups

 Intervention group:

 Better QOL scores  Less depression  More documentation of

resuscitation preferences

 Less aggressive care at the

end of life

 Lived two months longer

Skillful and Sensitive Communication

 Patients and families want their providers to:

 Bring up end of life issues  Be available and willing to talk AND listen  Provide timely and clear information  Encourage questions

 Patients tend to want:

 Prognostic information  For bad news to be delivered sensitively  Control over the timing of conversation  Active participation in decision-making, but desire

recommendations

Butow Support Care Cancer 2002 Gold Intern Med J 2009 Steinhauser J Pain and SxMgmt 2001 Wenrich Arch Int Med 2001

Yet, patients and families report…

 Not enough:

 Contact with physician 78%  Emotional support (pt): 51%  Info re: dying process: 50%  Emotional support (family): 38%  Help with pain/ dyspnea: 19%

 And a lack of:

 Coordination  Access  Anticipatory Guidance  Assurance Teno et al. JAMA 2004;291:88-93.

slide-7
SLIDE 7

3/22/2017 7

In general…

 We spend a lot of time talking  But sometimes, not enough  We interrupt a lot  We miss emotional cues  We lack education and

confidence

Tulsky Ann Int Med 1998 Anderson JGIM 2011 Marvel JAMA 1999 Levinson JAMA 2000 Ury Acad Med 2005

Audience Poll

The biggest barrier for me in having conversations about serious illness/ end-of-life with my patients is: 1. Knowledge (of how to have the conversation) 2. Time 3. Money (I can’t or don’t know how to bill) 4. Personal Discomfort - Fear of Taking Away Hope or Damaging the Relationship 5. None, this stuff is easy

Unique Opportunity in Primary Care

 Systematic review of 126 articles: 77 directly addressed

primary care, 26 addressed specific populations, 23 addressed general topics Strengths

  • Continuity
  • Duration
  • Trust
  • Ability to coordinate

across settings

  • Unique ability to have

these in an iterative manner Weaknesses

  • Deficits in knowledge,

skills, and attitudes

  • Discomfort with

prognostication

  • Lack of clarity about the

appropriate timing and initiation of conversations

Lakin J. JAMA Int Med 2016; 176(9):1380-1387

Key Communication Tools

 Asking for Permission

slide-8
SLIDE 8

3/22/2017 8

Key Communication Tools

 Ask for Permission  Respond to Emotion

 Practice: “

I feel like life is spiraling out of control”  Utilize Silence

 “Say something empathic and then just shut up.”

Name “It sounds like you’re frustrated.” Understand “It must be hard going through this alone.” Respect “I am so impressed by your commitment to your mother.” Support “I’ll be with you through all this.” Explore “Tell me more.”

Improving Communication

 VitalTalk

(www.vitaltalk.org)

Improving Communication (cont.)

 Readings

 Hashim MJ. Patient-Centered Communication: Basic Skills.

Am Fam Physician.2017 Jan 1;95(1):29-34.

 Ngo-Metzger Q, August KJ, Srinivasan M, Liao S, Meyskens FL

  • Jr. End-of-Lifecare: guidelines for patient-centered
  • communication. Am Fam Physician. 2008 Jan15;77(2):167-74.

 Eprognosis (ucsf.eprognosis.edu)

slide-9
SLIDE 9

3/22/2017 9

Advance Care Planning

 An ongoing p rocess of discussing care preferences

and making care plans between patients (a nd their ca regiv ers) and providers

 Should include discussion of person’s priorities,

beliefs, and values AND prognostic information

 May or may not lead to completion of advance

directive

 Both physicians and patients think it’s important

Benefits of ACP

35

 Patients who have advance care planning or EOL

conversations with their provider are:

 Less likely to receive intense interventions (mechanical

ventilation, CPR, die in ICU, use feeding tube) (Zhang et al. 2009,

Teno et al 2008, Wright et al. 2008, Brinkman-Stoppelenberg 2014)  More likely to received outpatient hospice and be referred to

hospice earlier (Zhang et al. 2009, Wright et al. 2008)

 More likely to have their interventions known and followed (Detering et al. 2010; Houbin 2014)  Family members are more likely to be satisfied with the quality

  • f death (Detering et al. 2010)

Audience Poll

In my practice, I aim to have advance care planning conversations with: 1. None of my patients

  • 2. All my patients over 65 years old
  • 3. My patients who are terminally ill
  • 4. Both 2 and 3
  • 5. All my patients regardless of age
slide-10
SLIDE 10

3/22/2017 10

ACP Practices in Primary Care

Glaudermans et al. (2015) Fam Practice

  • Systematic review of 10 studies (5 US) among PCPs providing

care for patients living in the community or an assisted living

  • ACP most frequently done with patients with cancer,

Alzheimer’s dementia, or other terminal illness

  • Of patients who died of non-sudden deaths, one-third had ACP
  • Provider-reported ACP rates higher than patient-reported ones
  • Lack of systematic approach; hard to judge when to initiate
  • Patients want to discuss, even if healthy; feel it is responsibility
  • f provider to bring up

ACP Documentation

 Include on problem list; be

specific

 Many health systems working

  • n streamlined EMR ACP

documentation processes

 When patient preferences

clear, complete advance directive and medical order (for patients with less than 1y prognosis; in states where available)

www.polst.org

ACP Billing

 ACP CPT codes NEW in 2016

 “ACP includes the explanation and discussion of advance

directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health professional”

 99497: first 30 min F2F (wRVU 2.40; $85.99)  99498: each additional 30 min F2F (wRVU 2.09; $74.99)  Include pertinent diagnoses; can bill more than once

 Medicare Annual Wellness Visit (AWV)

ACP Tools

www.prepareforyourcare.org

slide-11
SLIDE 11

3/22/2017 11

Miscellaneous PC Pearls

 “Easier to stay ahead of [insert symptom], than catch

up”

 Symptom management and ACP are PROCESSES  ”Patients (and families) aren’t always looking to be

"fixed," often they just want someone to listen to them, validate them, and bear witness to their story.”

Summary

 What doesn’t work…

 Docusate  Chemotherapy Near End of Life  IV Hydration Near End of life  Oxygen for Non-Hypoxic Patients

 What works!

 Palliative Care  Skillful and sensitive communication  Advance Care Planning